ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB166

Prevalence of Protein-Energy Wasting in Patients with CKD on Hemodialysis in Mexico

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Luna, Gabriela, Médica Santa Carmen, Querétaro, Mexico
  • Solis, Edgar, Médica Santa Carmen, Querétaro, Mexico
  • Martin-Alemañy, Geovana, University of Arizona, Nutritional Sciences and Wellness, Tucson, Arizona, United States
  • Davalos, Karla, Médica Santa Carmen, Querétaro, Mexico
  • Muñoz, Alondra, Médica Santa Carmen, Querétaro, Mexico
  • Escobar, María, Médica Santa Carmen, Querétaro, Mexico
  • Lagunes, Laura, Médica Santa Carmen, Querétaro, Mexico
  • Sepúlveda, Tania, Médica Santa Carmen, Querétaro, Mexico
  • Flores, Diana, Médica Santa Carmen, Querétaro, Mexico
  • Piña, Luz, Médica Santa Carmen, Querétaro, Mexico
  • Diez, Ingrid, Médica Santa Carmen, Querétaro, Mexico
  • Romero, Ludwig, Médica Santa Carmen, Querétaro, Mexico
  • Navarro, Jorge, Médica Santa Carmen, Querétaro, Mexico
  • Ardavin Ituarte, Juan M., Médica Santa Carmen, Querétaro, Mexico
  • Hernández-Estrada, Sergio, Médica Santa Carmen, Querétaro, Mexico
Background

The protein energy wasting (PEW) contributes to increasing the high rates of morbidity and mortality known in patients with chronic kidney disease. The objective of the study was to know the prevalence of PEW using the Malnutrition Inflammation Score (MIS).

Methods

In this multicenter cross-sectional study in adults hemodialysis (HD) patients the prevalence of PEW was calculated using the MIS tool for its diagnosis, its clinical and nutritional characteristics were described. Generalized linear model analysis was applied to evaluate the associations with different risk factors.

Results

3347 adult HD patients were evaluated from September 2020 to December 2023 from 11 kidney health facilities in Mexico. Prevalence of PEW was 35.5% (95% CI: 33.9% to 37.2%). It was observed that an increase in the triceps skinfold (OR: 0.95 95% CI 0.93-0.96), in the mid-arm muscle circumference (OR: 0.98 CI 95% 0.98-0.99) and serum creatinine (OR: 0.90 95% CI 0.87-0.93) were associated with a decrease in the probability of being diagnosed with PEW (p= 0.000).

Conclusion

We found a prevalence of PEW of 35.5% in patients on HD, these results are in line with what is reported in the literature where a worldwide prevalence has been calculated 28-54%.